Home/Filings/4/0001140361-14-012349
4//SEC Filing

Emergent BioSolutions Inc. 4

Accession 0001140361-14-012349

$EBSCIK 0001367644operating

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 3:12 PM ET

Size

7.3 KB

Accession

0001140361-14-012349

Insider Transaction Report

Form 4
Period: 2014-03-11
Labinger Barry
EVP, Biosciences Div.
Transactions
  • Award

    Common Stock

    2014-03-11$28.09/sh+14,060$394,94529,202 total
  • Award

    Employee Stock Option (right to buy)

    2014-03-11+28,11928,119 total
    Exercise: $28.09Exp: 2021-03-10Common Stock (28,119 underlying)
Footnotes (3)
  • [F1]Consists of restricted stock units granted under the Second Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
  • [F2]These restricted stock units vest in three equal annual installments beginning on the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
  • [F3]Vests in three equal installments on March 10, 2015, March 10, 2016 and March 10, 2017.

Documents

1 file

Issuer

Emergent BioSolutions Inc.

CIK 0001367644

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001367644

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 3:12 PM ET
Size
7.3 KB